BAM
GILD icon

Bellevue Asset Management’s Gilead Sciences GILD Stock Holding History

Bellevue Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87K Buy
688
+3
+0.4% +$395 0.04% 126
2026
Q1 		$95.5K Buy
685
+3
+0.4% +$420 0.05% 114
2025
Q4 		$83.8K Buy
682
+3
+0.4% +$365 0.03% 115
2025
Q3 		$75.4K Buy
679
+3
+0.4% +$341 0.03% 122
2025
Q2 		$75K Buy
676
+3
+0.4% +$319 0.04% 122
2025
Q1 		$75.5K Buy
673
+2
+0.3% +$206 0.04% 120
2024
Q4 		$62K Buy
671
+65
+11% +$5.85K 0.03% 134
2024
Q3 		$50.8K Buy
606
+2
+0.3% +$153 0.03% 160
2024
Q2 		$41.5K Buy
604
+4
+0.7% +$267 0.02% 164
2024
Q1 		$44K Sell
600
-164
-21% -$12.6K 0.03% 163
2023
Q4 		$61.9K Buy
764
+4
+0.5% +$311 0.05% 128
2023
Q3 		$57K Sell
760
-222
-23% -$17.1K 0.04% 124
2023
Q2 		$75.7K Buy
982
+3
+0.3% +$239 0.05% 107
2023
Q1 		$81.2K Buy
979
+3
+0.3% +$248 0.06% 101
2022
Q4 		$82.9K Hold
976
– – 0.06% 107
2022
Q3 		$60K Buy
976
+8
+0.8% +$504 0.05% 135
2022
Q2 		$60K Buy
968
+5
+0.5% +$310 0.04% 140
2022
Q1 		$58K Buy
963
+2
+0.2% +$128 0.04% 154
2021
Q4 		$70K Sell
961
-171
-15% -$11.8K 0.04% 144
2021
Q3 		$80K Buy
1,132
+78
+7% +$5.48K 0.05% 135
2021
Q2 		$73K Buy
1,054
+2
+0.2% +$134 0.04% 149
2021
Q1 		$68K Hold
1,052
– – 0.04% 151
2020
Q4 		$71K Buy
1,052
+52
+5% +$3.14K 0.04% 146
2020
Q3 		$63K Buy
1,000
+250
+33% +$17.3K 0.04% 139
2020
Q2 		$58K Buy
750
+75
+11% +$5.75K 0.06% 146
2020
Q1 		$53K Buy
675
+50
+8% +$3.46K 0.06% 160
2019
Q4 		$41K Buy
+625
New +$40.7K 0.03% 169

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bellevue Asset Management's GILD Position: Q2 2026 in Review

Bellevue Asset Management increased its Gilead Sciences (GILD) stake by 0.44% in Q2 2026, buying an estimated $395 and bringing the position to 688 shares worth $87K. The position accounts for 0.04% of the portfolio, ranked #126.

Bellevue Asset Management first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $95.5K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bellevue Asset Management held 688 shares of Gilead Sciences worth $87K as of Q2 2026.
  • Bellevue Asset Management bought 3 Gilead Sciences shares in Q2 2026, an estimated $395.
  • Gilead Sciences made up 0.04% of Bellevue Asset Management's portfolio in Q2 2026, its #126 holding.
  • Bellevue Asset Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Bellevue Asset Management's Gilead Sciences position peaked at $95.5K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.